SyntheticMR announced that their next-generation imaging solution with isotropic resolution, SyMRI 3D, has received FDA 510(k) clearance for clinical use in the United States.
SyntheticMR...
XtalPi Inc., a leading global technology company in integrating artificial intelligence (AI) and robotics to advance the discovery of groundbreaking medicine and innovative materials,...
Noetik, an AI-native biotechnology company leveraging advanced machine learning and proprietary data to discover and develop precision cancer immunotherapies announces the appointment of Dr....
Iambic Therapeutics, a biotechnology company developing novel therapeutics using its unique AI-driven discovery platform, announced that the first patient has been dosed in its...
Lunit, a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, announced the publication of a new study featuring Lunit SCOPE IO, Lunit's...
Biodesix, Inc., a leading diagnostic solutions company with a focus in lung diseases, announced that it has entered into a new master collaborative research...
A2 Biotherapeutics, Inc., a clinical-stage cell therapy company developing first-in-class logic-gated cell therapies to address the high unmet needs in cancer, announced the appointment...
VRG50635 is one of the first clinical-stage drugs discovered and developed entirely using an AI-powered platform
Verge Genomics, a leading clinical-stage biotechnology company, and Ferrer,...
AI combined with expert guidance to better support medical affairs by delivering insights rooted in real data for more impactful communications
Lumanity, a global life...